EligibleTrials

Clinical trials recruiting for Secondary-progressive Multiple Sclerosis (SPMS)

4
Recruiting trials
19
US states with sites
33
Countries
25%
Accept healthy volunteers

Phase breakdown

Phase 1 1Phase 2 2Phase 3 1Not applicable 1

Drugs and treatments being studied

InterventionTrials
Bendamustine1
Remibrutinib (Open label)1
Remibrutinib (blinded)1
Rituximab1
TRX3191

Where trials are recruiting (top US states)

StateRecruiting trials
Kansas2
Alabama1
Arizona1
California1
Colorado1
District of Columbia1
Florida1
Georgia1
Hawaii1
Illinois1
Maryland1
Massachusetts1

Top cities

Kansas City, Kansas 2Albuquerque, New Mexico 1Altamonte Springs, Florida 1Aurora, Colorado 1Bethesda, Maryland 1Birmingham, Alabama 1Chicago, Illinois 1Cordova, Tennessee 1Dallas, Texas 1Farmington Hills, Michigan 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Secondary-progressive Multiple Sclerosis (SPMS) often also study these conditions. Each links to its own recruiting-trial list.

Multiple sclerosis 445Relapsing-remitting Multiple Sclerosis (RRMS) 6Primary Progressive Multiple Sclerosis 3Multiple Sclerosis (MS) Secondary Progressive 5Multiple Sclerosis (MS) Primary Progressive 6Multiple Sclerosis (MS) 14

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Secondary-progressive Multiple Sclerosis (SPMS) trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.